Profile data is unavailable for this security.
About the company
Medicamen Organics Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and distribution of a range of pharmaceutical dosages, including generic dosage in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspension, and dry powders for governments (including both state and central governments) and private institutions as contract manufacturer/third party manufacturer. Its product portfolio consists of over 84 products and comprises a range of drugs such as antibacterial, anti-diarrheal, antifungal, anti-malarial, anti-diabetic, proton pump inhibitor, antihistamine, antihypertensive drugs, anti-lipidemic drug, antiparasitic, multivitamin, multimineral and non-steroidal anti-inflammatory drug (NSAIDS). Its products are marketed across India as well as African, CIS and southeast Asian Countries, such as Congo, Benin, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan, and Kenya.
- Revenue in INR (TTM)394.30m
- Net income in INR45.74m
- Incorporated1995
- Employees114.00
- LocationMedicamen Organics Ltd10 Community CentreNo 2 Ashok Vihar, Phase IiNEW DELHI 110052IndiaIND
- Phone+91 1 127430249
- Websitehttps://www.medicamenorganics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicamen Organics Ltd | 394.30m | 45.74m | 321.17m | 114.00 | 7.15 | 0.9846 | 5.99 | 0.8145 | 3.84 | 3.84 | 33.10 | 27.88 | 0.716 | 3.30 | 1.63 | 3,458,737.00 | 8.31 | -- | 14.41 | -- | 38.03 | -- | 11.60 | -- | 1.46 | 10.71 | 0.3218 | -- | 51.11 | -- | 54.22 | -- | -- | -- |
| Medistep Healthcare Ltd | 634.72m | 54.27m | 336.77m | 9.00 | 5.46 | 0.9674 | 6.17 | 0.5306 | 4.34 | 4.34 | 49.60 | 24.50 | -- | -- | -- | 70,524,340.00 | -- | -- | -- | -- | 12.62 | -- | 8.55 | -- | 4.79 | 854.24 | 0.0167 | -- | 27.09 | -- | 24.54 | -- | -- | -- |
| JFL Life Sciences Ltd | 800.66m | 47.93m | 395.94m | 39.00 | 8.21 | -- | 6.62 | 0.4945 | 1.46 | 1.46 | 24.37 | -- | -- | -- | -- | -- | -- | 5.83 | -- | 10.64 | 22.23 | 18.28 | 6.02 | 5.73 | -- | 5.95 | -- | -- | 76.25 | 22.15 | 25.72 | 63.09 | -32.30 | -- |
| Jupiter Bioscience Ltd | -100.00bn | -100.00bn | 399.59m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.42 | -- | 5.61 | -- | 61.37 | -- | 17.32 | -- | -- | -- | 10.48 | 42.43 | 29.30 | 20.92 | 22.82 | 55.40 | -16.74 |
